pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3942 |
Genomic Coordinates | chr15: 35372256 - 35372364 |
Description | Homo sapiens miR-3942 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3942-3p | ||||||||||||||||||||||||||||
Sequence | 65| UUUCAGAUAACAGUAUUACAU |85 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NPEPPS | ||||||||||||||||||||
Synonyms | AAP-S, MP100, PSA | ||||||||||||||||||||
Description | aminopeptidase puromycin sensitive | ||||||||||||||||||||
Transcript | NM_006310 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NPEPPS | |||||||||||||||||||||
3'UTR of NPEPPS (miRNA target sites are highlighted) |
>NPEPPS|NM_006310|3'UTR 1 ATCCTGAGGTGCCGCCATTGGCGGTTCTGCTGCTTCGCTGCAGGGATAAGGTGGAGCTACCGAACAGCTGATTCATATGC 81 CAAGAATTTGGAGTCTTCTTTCAAACCAGTGGGGGTTGGACAATGAATGTAGTTAACTGGTTCCTGCTCACACTCCAGAA 161 TTAAATTCTATTGAAAAAGGAAAATCAGCAATTCAGCAAAAAATAAATAAAAAATAAAAATGTAAATATGATAGTAATAA 241 AATAGAGCATAACGAAACTGTGAAACTTTCTGAAGCCTTGTCAGTGGTTAAAAGTATTTAACACTCTACTGTTAATGACA 321 GATGTTCTGTTTTTATAACCTACCAAAAGGAAACTAGAGGCTTCTTGGTGAAGAGCATTTTTGTGAAGTGGGTTCTGCAA 401 GGAGCCTATAAAGCCAAGGGTGGTGTCCATTTCTGGGAATGGTTAAACACAAAAGGCTGATAGCTGGTATCACATAGTTG 481 GAGTCAGTGCATAATTCCAAGTGGCTTTTTTTTTTTTTGGCACGGGGACTGATCAGGAAGATATATTCCTGCATAACTCA 561 ATCTGAACCAAGGATTGTAGTTTAGTTTTCCTCCTTGCCTTCCCTTCTGTGTGACCGACCCCTTGGCCAAAAAAAAACAA 641 AAAGCAAAAAACAAAAACCTACCCTGTTCTGGTTTTTTTCCTCCCTTTAGTTCCACCCCCAACCCCCATTCCCTGGTGTC 721 CTTCTTAGAGATGAAGAAATAATAAGGAAACATCTTTCATAGCCACATTAAATAAGAGAAACTGATATACATTATTTTTT 801 TCTTTTTAAAGATGACTTATAAGAACCCTGAAATTTATATAGGTGAGACAATAGAAATAAAAAGATCTTCAGCCAGGCCT 881 TTCTGAAGGAGTTATTCTGCTAAAAATGGTCTTAGTTGTCTGAAAAGCCAGCTCTTGAACCTCTTCACAACAGTATCAAC 961 ACTGGCTTCTCCCGGTTCATTTTATGCGTGCGAGAAGTCAGTGGTAACTGCTGCAGGGCTTAATACATTAGTGGTAACTG 1041 GTTTAAAAAACAAAGACTGTAAGCCTGTGTGTGCCACTGTTTGCTTCAACAGTATATCCTAATAAGCCTCACCTATTTAA 1121 TCCAATGAGTTTTAAATCTAAATCTCATTCCCTTCTTCTTTCCCTACCTTTTTTTTCTTTTTTTCTTAAAAAAATATTTT 1201 GTGTTATTAACAGAAATTCATATTTGGTGTGGCTTAACGGTATTTCAGAAGGTCATCAGATTGTGAGACTGCTTCCTTGA 1281 AACATTTTTGTGCTATTGTTTTAAAAAAATAATTAAAAAACAGTTGGCGTTAATAAAAATGTCAATGTGAAACTGAAAAA 1361 AAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C8166 , TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_006310 | 3UTR | AGAGAAACUGAUAUACAUUAUUUUUUUCUUUUUAAAGAUGACUUAUAAGAACCCUGAAAUUUAUAUAGGUGAGACAAUAGAAAUAAAAAGAUCUUCAGCCAGGCCUUUCUGAAGGAGUUAUUCUGCUAAAAAUGGUCUUAGUUGUCUGAAAAGCCAGCUCUUGAACCUCUUCACAACAGUAUCAACACUGGCUUCUCCCGGUUCAUUUUAUGCGUGCGAGAAGUCAGUGGUAACUGCUGCAGGGCUUAAUACAUUAGUGGUAACUGGUUUAAAAAACAAAGACUGUAAGCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_006310 | 3UTR | GAAAAGCCAGCUCUUGAACCUCUUCACAACAGUAUCAACACUGGCUUCUCCCGGUUCAUUUUAUGCGUGCGAGAAGUCAGUGGUAACUGCUGCAGGGCUUAAUACAUUAGUGGUAACUGGUUUAAAAAACAAAGACUGUAAGCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_006310 | 3UTR | CUUAGUUGUCUGAAAAGCCAGCUCUUGAACCUCUUCACAACAGUAUCAACACUGGCUUCUCCCGGUUCAUUUUAUGCGUGCGAGAAGUCAGUGGUAACUGCUGCAGGGCUUAAUACAUUAGUGGUAACUGGUUUAAAAAACAAAGACUGUAAGCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_006310 | 3UTR | CUUAGUUGUCUGAAAAGCCAGCUCUUGAACCUCUUCACAACAGUAUCAACACUGGCUUCUCCCGGUUCAUUUUAUGCGUGCGAGAAGUCAGUGGUAACUGCUGCAGGGCUUAAUACAUUAGUGGUAACUGGUUUAAAAAACAAAGACUGUAAGCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_006310 | 3UTR | UCUUAGUUGUCUGAAAAGCCAGCUCUUGAACCUCUUCACAACAGUAUCAACACUGGCUUCUCCCGGUUCAUUUUAUGCGUGCGAGAAGUCAGUGGUAACUGCUGCAGGGCUUAAUACAUUAGUGGUAACUGGUUUAAAAAACAAAGACUGUAAGCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000322157.4 | 3UTR | AUAUAUUCCUGCAUAACUCAAUCUGAACCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000322157.4 | 3UTR | AUAUAUUCCUGCAUAACUCAAUCUGAACCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
116 hsa-miR-3942-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT093395 | TMA16 | translation machinery associated 16 homolog | 2 | 2 | ||||||||
MIRT134018 | SDE2 | SDE2 telomere maintenance homolog | 2 | 2 | ||||||||
MIRT194942 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT265807 | NOTCH2 | notch 2 | 2 | 2 | ||||||||
MIRT287615 | NPEPPS | aminopeptidase puromycin sensitive | 2 | 2 | ||||||||
MIRT444196 | SESN3 | sestrin 3 | 2 | 2 | ||||||||
MIRT444480 | UBN2 | ubinuclein 2 | 2 | 2 | ||||||||
MIRT446589 | FBXO40 | F-box protein 40 | 2 | 2 | ||||||||
MIRT450501 | ALPK3 | alpha kinase 3 | 2 | 2 | ||||||||
MIRT455182 | AGTRAP | angiotensin II receptor associated protein | 2 | 2 | ||||||||
MIRT455446 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | 2 | 2 | ||||||||
MIRT456385 | KLHL12 | kelch like family member 12 | 2 | 2 | ||||||||
MIRT460303 | FLCN | folliculin | 2 | 2 | ||||||||
MIRT461247 | COX10 | COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor | 2 | 6 | ||||||||
MIRT467948 | SLC16A1 | solute carrier family 16 member 1 | 2 | 2 | ||||||||
MIRT468007 | SIX4 | SIX homeobox 4 | 2 | 2 | ||||||||
MIRT468211 | SGK1 | serum/glucocorticoid regulated kinase 1 | 2 | 2 | ||||||||
MIRT470635 | POM121C | POM121 transmembrane nucleoporin C | 2 | 2 | ||||||||
MIRT471785 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 2 | ||||||||
MIRT473557 | MATR3 | matrin 3 | 2 | 2 | ||||||||
MIRT475415 | ICK | intestinal cell kinase | 2 | 2 | ||||||||
MIRT476265 | GNAL | G protein subunit alpha L | 2 | 6 | ||||||||
MIRT477135 | FAM107B | family with sequence similarity 107 member B | 2 | 6 | ||||||||
MIRT478433 | DAZAP2 | DAZ associated protein 2 | 2 | 2 | ||||||||
MIRT479050 | CNOT6L | CCR4-NOT transcription complex subunit 6 like | 2 | 8 | ||||||||
MIRT480872 | BDNF-AS | BDNF antisense RNA | 2 | 2 | ||||||||
MIRT484229 | CLDN1 | claudin 1 | 2 | 2 | ||||||||
MIRT485055 | SUCO | SUN domain containing ossification factor | 2 | 2 | ||||||||
MIRT489871 | MPLKIP | M-phase specific PLK1 interacting protein | 2 | 2 | ||||||||
MIRT492411 | SCARB2 | scavenger receptor class B member 2 | 2 | 2 | ||||||||
MIRT499682 | KCTD2 | potassium channel tetramerization domain containing 2 | 2 | 4 | ||||||||
MIRT505969 | RAB11FIP1 | RAB11 family interacting protein 1 | 2 | 4 | ||||||||
MIRT507708 | CNIH | cornichon family AMPA receptor auxiliary protein 1 | 2 | 4 | ||||||||
MIRT511878 | GID4 | GID complex subunit 4 homolog | 2 | 6 | ||||||||
MIRT513411 | RTP4 | receptor transporter protein 4 | 2 | 2 | ||||||||
MIRT519873 | ZFP30 | ZFP30 zinc finger protein | 2 | 4 | ||||||||
MIRT520703 | TMCO1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT522890 | KCNN3 | potassium calcium-activated channel subfamily N member 3 | 2 | 6 | ||||||||
MIRT523781 | FAM63B | MINDY lysine 48 deubiquitinase 2 | 2 | 2 | ||||||||
MIRT523950 | DYNLT1 | dynein light chain Tctex-type 1 | 2 | 4 | ||||||||
MIRT526894 | ATP6V0E2 | ATPase H+ transporting V0 subunit e2 | 2 | 2 | ||||||||
MIRT529167 | CCDC25 | coiled-coil domain containing 25 | 2 | 2 | ||||||||
MIRT529703 | ZBTB49 | zinc finger and BTB domain containing 49 | 2 | 2 | ||||||||
MIRT530359 | PCSK1 | proprotein convertase subtilisin/kexin type 1 | 2 | 2 | ||||||||
MIRT530595 | C7orf33 | chromosome 7 open reading frame 33 | 2 | 4 | ||||||||
MIRT531528 | CCT6A | chaperonin containing TCP1 subunit 6A | 2 | 2 | ||||||||
MIRT531992 | BARD1 | BRCA1 associated RING domain 1 | 2 | 2 | ||||||||
MIRT539547 | AAK1 | AP2 associated kinase 1 | 2 | 2 | ||||||||
MIRT547757 | KATNAL1 | katanin catalytic subunit A1 like 1 | 2 | 2 | ||||||||
MIRT549059 | CAMSAP1 | calmodulin regulated spectrin associated protein 1 | 2 | 2 | ||||||||
MIRT549836 | ECHDC1 | ethylmalonyl-CoA decarboxylase 1 | 2 | 2 | ||||||||
MIRT552698 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta | 2 | 2 | ||||||||
MIRT554318 | SH3GLB1 | SH3 domain containing GRB2 like, endophilin B1 | 2 | 2 | ||||||||
MIRT556358 | MAF | MAF bZIP transcription factor | 2 | 2 | ||||||||
MIRT557772 | FRS2 | fibroblast growth factor receptor substrate 2 | 2 | 2 | ||||||||
MIRT558795 | CHEK2 | checkpoint kinase 2 | 2 | 2 | ||||||||
MIRT561367 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT561673 | RAPGEF2 | Rap guanine nucleotide exchange factor 2 | 2 | 2 | ||||||||
MIRT567898 | CSNK1A1 | casein kinase 1 alpha 1 | 2 | 2 | ||||||||
MIRT568456 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT568838 | NBPF12 | NBPF member 12 | 2 | 2 | ||||||||
MIRT568846 | VPS53 | VPS53, GARP complex subunit | 2 | 2 | ||||||||
MIRT568856 | NBPF1 | NBPF member 1 | 2 | 2 | ||||||||
MIRT568888 | NBPF15 | NBPF member 15 | 2 | 2 | ||||||||
MIRT569331 | CDC5L | cell division cycle 5 like | 2 | 2 | ||||||||
MIRT569388 | NBPF11 | NBPF member 11 | 2 | 2 | ||||||||
MIRT569398 | NBPF14 | NBPF member 14 | 2 | 2 | ||||||||
MIRT569644 | NBPF10 | NBPF member 10 | 2 | 2 | ||||||||
MIRT571582 | TROVE2 | TROVE domain family member 2 | 2 | 2 | ||||||||
MIRT573027 | NBPF3 | NBPF member 3 | 2 | 2 | ||||||||
MIRT573293 | UFM1 | ubiquitin fold modifier 1 | 2 | 2 | ||||||||
MIRT608814 | SEPT6 | septin 6 | 2 | 6 | ||||||||
MIRT609046 | BACH2 | BTB domain and CNC homolog 2 | 2 | 6 | ||||||||
MIRT609517 | RAB3IP | RAB3A interacting protein | 2 | 2 | ||||||||
MIRT611861 | SRRM4 | serine/arginine repetitive matrix 4 | 2 | 2 | ||||||||
MIRT612174 | EMC3 | ER membrane protein complex subunit 3 | 2 | 2 | ||||||||
MIRT612714 | NR2F6 | nuclear receptor subfamily 2 group F member 6 | 2 | 4 | ||||||||
MIRT613305 | ARL6IP6 | ADP ribosylation factor like GTPase 6 interacting protein 6 | 2 | 4 | ||||||||
MIRT616357 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT632424 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT636005 | SAMD15 | sterile alpha motif domain containing 15 | 2 | 2 | ||||||||
MIRT636534 | FAM126B | family with sequence similarity 126 member B | 2 | 2 | ||||||||
MIRT637275 | FGFR1OP | FGFR1 oncogene partner | 2 | 2 | ||||||||
MIRT639131 | ZNF726 | zinc finger protein 726 | 2 | 2 | ||||||||
MIRT641257 | C8orf46 | chromosome 8 open reading frame 46 | 2 | 2 | ||||||||
MIRT642930 | KRTAP5-9 | keratin associated protein 5-9 | 2 | 2 | ||||||||
MIRT644018 | NUCB1 | nucleobindin 1 | 2 | 2 | ||||||||
MIRT645021 | MAGEB4 | MAGE family member B4 | 2 | 2 | ||||||||
MIRT646790 | EVC2 | EvC ciliary complex subunit 2 | 2 | 2 | ||||||||
MIRT647338 | RPH3AL | rabphilin 3A like (without C2 domains) | 2 | 2 | ||||||||
MIRT647975 | PDE12 | phosphodiesterase 12 | 2 | 2 | ||||||||
MIRT650610 | NEK4 | NIMA related kinase 4 | 2 | 2 | ||||||||
MIRT651052 | ZNF579 | zinc finger protein 579 | 2 | 2 | ||||||||
MIRT651593 | WDFY2 | WD repeat and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT652785 | TCEANC2 | transcription elongation factor A N-terminal and central domain containing 2 | 2 | 2 | ||||||||
MIRT656450 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 2 | ||||||||
MIRT660086 | BTD | biotinidase | 2 | 2 | ||||||||
MIRT661398 | OLR1 | oxidized low density lipoprotein receptor 1 | 2 | 2 | ||||||||
MIRT661759 | MICA | MHC class I polypeptide-related sequence A | 2 | 2 | ||||||||
MIRT666402 | SH3D19 | SH3 domain containing 19 | 2 | 2 | ||||||||
MIRT668362 | FGD4 | FYVE, RhoGEF and PH domain containing 4 | 2 | 2 | ||||||||
MIRT668895 | CREG2 | cellular repressor of E1A stimulated genes 2 | 2 | 2 | ||||||||
MIRT669329 | BSND | barttin CLCNK type accessory beta subunit | 2 | 2 | ||||||||
MIRT672369 | PDPK1 | 3-phosphoinositide dependent protein kinase 1 | 2 | 2 | ||||||||
MIRT686261 | YTHDF1 | YTH N6-methyladenosine RNA binding protein 1 | 2 | 2 | ||||||||
MIRT695571 | ASB16 | ankyrin repeat and SOCS box containing 16 | 2 | 2 | ||||||||
MIRT701959 | MINK1 | misshapen like kinase 1 | 2 | 2 | ||||||||
MIRT702322 | KMT2A | lysine methyltransferase 2A | 2 | 2 | ||||||||
MIRT705209 | BRWD1 | bromodomain and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT713949 | KCTD6 | potassium channel tetramerization domain containing 6 | 2 | 2 | ||||||||
MIRT717082 | EBF4 | early B-cell factor 4 | 2 | 2 | ||||||||
MIRT717896 | COPS8 | COP9 signalosome subunit 8 | 2 | 2 | ||||||||
MIRT721043 | TRIM67 | tripartite motif containing 67 | 2 | 2 | ||||||||
MIRT722194 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT722782 | ACADSB | acyl-CoA dehydrogenase, short/branched chain | 2 | 2 | ||||||||
MIRT725412 | HNRNPU | heterogeneous nuclear ribonucleoprotein U | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|